Pharming Group N.V. (PHAR) Enterprise Value (2019 - 2024)
Pharming (PHAR) has disclosed Enterprise Value for 3 consecutive years, with -$207.3 million as the latest value for Q4 2022.
- For the quarter ending Q4 2022, Enterprise Value fell 8.03% year-over-year to -$207.3 million, compared with a TTM value of -$207.3 million through Dec 2022, down 8.03%, and an annual FY2022 reading of -$207.3 million, down 8.03% over the prior year.
- Enterprise Value was -$207.3 million for Q4 2022 at Pharming, down from -$191.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$191.9 million in Q4 2021 and bottomed at -$207.3 million in Q4 2022.
- Average Enterprise Value over 3 years is -$199.5 million, with a median of -$199.2 million recorded in 2020.
- The sharpest move saw Enterprise Value increased 3.65% in 2021, then dropped 8.03% in 2022.
- Year by year, Enterprise Value stood at -$199.2 million in 2020, then rose by 3.65% to -$191.9 million in 2021, then fell by 8.03% to -$207.3 million in 2022.
- Business Quant data shows Enterprise Value for PHAR at -$207.3 million in Q4 2022, -$191.9 million in Q4 2021, and -$199.2 million in Q4 2020.